Patent details

Basic Information

Publication number:

EP1290011

PCT Application Number:

PCT/SE/2001/001318

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP019389451

PCT Publication Number:

WO/2001/096367

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

MELPHALAN DERIVATIVES AND THEIR USE AS CANCER CHEMOTHERAPEUTIC DRUGS

French Title of Invention:

DERIVES DE MELPHALAN ET LEUR UTILISATION COMME PRODUITS CHIMIOTHERAPEUTIQUES CONTRE LE CANCER

German Title of Invention:

MELPHALAN-DERIVATE UND IHRE VERWENDUNG ALS CHEMOTHERAPEUTIKA GEGEN KREBS

SPC Number:

Dates

Filing date:

11/06/2001

Grant date:

24/02/2010

EP Publication Date:

24/02/2010

PCT Publication Date:

20/12/2001

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

12/03/2003

EP B1 Publication Date:

24/02/2010

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/06/2010

Expiration date:

11/06/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/06/2001

 

 

Name:

Oncopeptides AB

Address:

Tors Väg 12, 182 35 Danderyd, Sweden (SE)

Inventor

1

Name:

EHRSSON Hans

Address:

Sweden (SE)

2

Name:

LARSSON Rolf

Address:

Sweden (SE)

3

Name:

GULLBO Joakim

Address:

Sweden (SE)

4

Name:

LEWENSOHN Rolf

Address:

Sweden (SE)

5

Name:

LUTHMAN Kristina

Address:

Sweden (SE)

Priority

1

Priority Number:

0002202

Priority Date:

13/06/2000

Priority Country:

Sweden (SE)

2

Priority Number:

211227 P

Priority Date:

13/06/2000

Priority Country:

United States (US)

Classification

Main IPC Class:

C07K 5/06;

Filing date	Document type	Number of pages